Literature DB >> 14761725

In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.

Montserrat Ortoneda1, Javier Capilla, F Javier Pastor, Isabel Pujol, Josep Guarro.   

Abstract

We have studied the in vitro interactions of amphotericin B (AMB) with terbinafine (TBF), itraconazole, voriconazole (VCZ), albaconazole, and ravuconazole (RVZ), as well as TBF combined with the same azoles, against 11 isolates of Fusarium spp. using the fractional inhibitory concentration index. The highest percentage of synergistic interactions was observed for the combinations AMB-RVZ, TBF-VCZ, and TBF-RCZ.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14761725     DOI： 10.1016/j.diagmicrobio.2003.09.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  10 in total

1.  Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model.

Authors:  Michael J Dolton; Vidya Perera; Lisa G Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

Review 2.  Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature.

Authors:  Greg P Bourgeois; Jennifer A Cafardi; Klaus Sellheyer; Aleodor A Andea
Journal:  Cutis       Date:  2010-04

3.  Posaconazole in the treatment of refractory Purpureocillium lilacinum (former Paecilomyces lilacinus) keratitis: the salvation when nothing works.

Authors:  Mariana Almeida Oliveira; Analia Carmo; Andreia Rosa; Joaquim Murta
Journal:  BMJ Case Rep       Date:  2019-04-11

Review 4.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.

Authors:  Mery Ruíz-Cendoya; Marçal Mariné; M M Rodríguez; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 6.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

7.  In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

8.  Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.

Authors:  José-Manuel Vagace; Cesar Sanz-Rodriguez; Maria-Soledad Casado; Nieves Alonso; Manuel Garcia-Dominguez; Francisco Garcia de la Llana; Luis Zarallo; Miguel Fajardo; Roberto Bajo
Journal:  BMC Infect Dis       Date:  2007-05-10       Impact factor: 3.090

9.  Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience.

Authors:  Jessica M Stempel; Sarah P Hammond; Deanna A Sutton; Linda M Weiser; Francisco M Marty
Journal:  Open Forum Infect Dis       Date:  2015-07-04       Impact factor: 3.835

Review 10.  Treatment of a Locally Invasive Cutaneous Fusarium Species Infection With Voriconazole and Liposomal Amphotericin B in a Patient With Relapsed Acute Myeloid Leukemia.

Authors:  Sara Anne Meyer; Bruce M Jones
Journal:  J Adv Pract Oncol       Date:  2017-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.